Molecular Pharmacology: 41 (5)

May 01, 1992; Volume 41,Issue 5

You have access
Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor.
J Krause, C Eva, P H Seeburg and R Sprengel

Molecular Pharmacology May 1992, 41 (5) 817-821;
You have access
Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells.
S C Roerig, H H Loh and P Y Law

Molecular Pharmacology May 1992, 41 (5) 822-831;
You have access
Multiple states of rat brain (RS)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors as revealed by quantitative autoradiography.
J H Cha, R L Makowiec, J B Penney and A B Young

Molecular Pharmacology May 1992, 41 (5) 832-838;
You have access
Chronic selegiline administration transiently decreases tyrosine hydroxylase activity and mRNA in the rat nigrostriatal pathway.
S L Vrana, A J Azzaro and K E Vrana

Molecular Pharmacology May 1992, 41 (5) 839-844;
You have access
DNA-binding properties of a distamycin-ellipticine hybrid molecule.
C Bailly, C O'Huigin, R Houssin, P Colson, C Houssier, C Rivalle, E Bisagni, J P Henichart and M J Waring

Molecular Pharmacology May 1992, 41 (5) 845-855;
You have access
Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens.
T Shimada, C H Yun, H Yamazaki, J C Gautier, P H Beaune and F P Guengerich

Molecular Pharmacology May 1992, 41 (5) 856-864;
You have access
Human liver dehydroepiandrosterone sulfotransferase: molecular cloning and expression of cDNA.
D M Otterness, E D Wieben, T C Wood, W G Watson, B J Madden, D J McCormick and R M Weinshilboum

Molecular Pharmacology May 1992, 41 (5) 865-872;
You have access
Characterization of a 5-lipoxygenase-activating protein binding assay: correlation of affinity for 5-lipoxygenase-activating protein with leukotriene synthesis inhibition.
S Charleson, P Prasit, S Léger, J W Gillard, P J Vickers, J A Mancini, P Charleson, J Guay, A W Ford-Hutchinson and J F Evans

Molecular Pharmacology May 1992, 41 (5) 873-879;
You have access
Differences in effects of forskolin and an analog on calcium currents in cardiac myocytes suggest intra- and extracellular sites of action.
H C Hartzell and D Budnitz

Molecular Pharmacology May 1992, 41 (5) 880-888;
You have access
Beta 1- and beta 2-adrenergic receptors display subtype-selective coupling to Gs.
S A Green, B D Holt and S B Liggett

Molecular Pharmacology May 1992, 41 (5) 889-893;
You have access
Stimulation of adenylate cyclase by amylin in CHO-K1 cells.
C S D'Santos, A Gatti, D R Poyner and M R Hanley

Molecular Pharmacology May 1992, 41 (5) 894-899;
You have access
Effects of low doses of bicuculline on N-methyl-D-aspartate single-channel kinetics are not evident in whole-cell currents.
J M Wright and L M Nowak

Molecular Pharmacology May 1992, 41 (5) 900-907;
You have access
Forskolin acts as a noncompetitive inhibitor of nicotinic acetylcholine receptors.
M L Aylwin and M M White

Molecular Pharmacology May 1992, 41 (5) 908-913;
You have access
Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
A C Foster, J A Kemp, P D Leeson, S Grimwood, A E Donald, G R Marshall, T Priestley, J D Smith and R W Carling

Molecular Pharmacology May 1992, 41 (5) 914-922;
You have access
Characterization of the binding of [3H]L-689,560, an antagonist for the glycine site on the N-methyl-D-aspartate receptor, to rat brain membranes.
S Grimwood, A M Moseley, R W Carling, P D Leeson and A C Foster

Molecular Pharmacology May 1992, 41 (5) 923-930;
You have access
Nicotinic acetylcholine currents in cultured postnatal rat hippocampal neurons.
C F Zorumski, L L Thio, K E Isenberg and D B Clifford

Molecular Pharmacology May 1992, 41 (5) 931-936;
You have access
Ambenonium is a rapidly reversible noncovalent inhibitor of acetylcholinesterase, with one of the highest known affinities.
A S Hodge, D R Humphrey and T L Rosenberry

Molecular Pharmacology May 1992, 41 (5) 937-942;
You have access
Free radical metabolism of halothane in vivo: radical adducts detected in bile.
K T Knecht, J A DeGray and R P Mason

Molecular Pharmacology May 1992, 41 (5) 943-949;
You have access
Membrane permeation characteristics of 5'-modified thymidine analogs.
B A Domin, W B Mahony, G W Koszalka, D J Porter, G Hajian and T P Zimmerman

Molecular Pharmacology May 1992, 41 (5) 950-956;
You have access
Role of desolvation energy in the nonfacilitated membrane permeability of dideoxyribose analogs of thymidine.
L L Wright and G R Painter

Molecular Pharmacology May 1992, 41 (5) 957-962;
You have access
Common features in the interaction of tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives with the human immunodeficiency virus type 1 reverse transcriptase.
Z Debyser, R Pauwels, M Baba, J Desmyter and E De Clercq

Molecular Pharmacology May 1992, 41 (5) 963-968;
You have access
Effects of L-histidine on hydrogen peroxide-induced DNA damage and cytotoxicity in cultured mammalian cells.
O Cantoni, P Sestili, A Guidarelli, P U Giacomoni and F Cattabeni

Molecular Pharmacology May 1992, 41 (5) 969-974;
You have access
Human liver microsomal N-hydroxylation of dapsone by cytochrome P-4503A4.
C M Fleming, R A Branch, G R Wilkinson and F P Guengerich

Molecular Pharmacology May 1992, 41 (5) 975-980;
You have access
Imprinting of hepatic microsomal cytochrome P-450 enzyme activities and cytochrome P-450IIC11 by peripubertal administration of testosterone in female rats.
B J Cadario, G D Bellward, S Bandiera, T K Chang, W W Ko, E Lemieux and R C Pak

Molecular Pharmacology May 1992, 41 (5) 981-988;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals